Grassi ES - Search Results

1

Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness.

Grassi ES, Pietras A. Grassi ES, et al. J Histochem Cytochem. 2022 Jan;70(1):17-28. doi: 10.1369/00221554211048951. Epub 2021 Oct 4. J Histochem Cytochem. 2022. PMID: 34606325 Free PMC article. Review.

2

CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.

Johansson E, Grassi ES, Pantazopoulou V, Tong B, Lindgren D, Berg TJ, Pietras EJ, Axelson H, Pietras A. Johansson E, et al. Among authors: grassi es. Cell Rep. 2017 Aug 15;20(7):1641-1653. doi: 10.1016/j.celrep.2017.07.049. Cell Rep. 2017. PMID: 28813675 Free article.

3

Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma.

Grassi ES, Pantazopoulou V, Pietras A. Grassi ES, et al. Oncogene. 2020 May;39(20):4028-4044. doi: 10.1038/s41388-020-1273-9. Epub 2020 Mar 24. Oncogene. 2020. PMID: 32205867 Free PMC article.

4

Niche-derived soluble DLK1 promotes glioma growth.

Grassi ES, Jeannot P, Pantazopoulou V, Berg TJ, Pietras A. Grassi ES, et al. Neoplasia. 2020 Dec;22(12):689-701. doi: 10.1016/j.neo.2020.10.005. Epub 2020 Oct 23. Neoplasia. 2020. PMID: 33142235 Free PMC article.

5

Thyrotropin Receptor p.N432D Retained Variant Is Degraded Through an Alternative Lysosomal/Autophagosomal Pathway and Can Be Functionally Rescued by Chemical Chaperones.

Grassi ES, Lábadi A, Vezzoli V, Ghiandai V, Bonomi M, Persani L. Grassi ES, et al. Thyroid. 2021 Jul;31(7):1030-1040. doi: 10.1089/thy.2020.0415. Epub 2021 Feb 22. Thyroid. 2021. PMID: 33446056 Free article.

6

Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies.

Grassi ES, Ghiandai V, Persani L. Grassi ES, et al. J Clin Med. 2021 Apr 1;10(7):1455. doi: 10.3390/jcm10071455. J Clin Med. 2021. PMID: 33916320 Free PMC article. Review.

7

FAM83B is involved in thyroid cancer cell differentiation and migration.

Cirello V, Grassi ES, Pogliaghi G, Ghiandai V, Ermellino L, Muzza M, Gazzano G, Persani L, Colombo C, Fugazzola L. Cirello V, et al. Among authors: grassi es. Sci Rep. 2022 May 21;12(1):8608. doi: 10.1038/s41598-022-12553-2. Sci Rep. 2022. PMID: 35597845 Free PMC article.

8

8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.

Grassi ES, Dicitore A, Negri I, Borghi MO, Vitale G, Persani L. Grassi ES, et al. Endocrine. 2017 May;56(2):388-398. doi: 10.1007/s12020-016-1057-8. Epub 2016 Jul 27. Endocrine. 2017. PMID: 27460006

9

Role of Epigenetic Therapy in the Modulation of Tumor Growth and Migration in Human Castration-Resistant Prostate Cancer Cells with Neuroendocrine Differentiation.

Dicitore A, Bacalini MG, Saronni D, Gaudenzi G, Cantone MC, Gelmini G, Grassi ES, Gentilini D, Borghi MO, Di Blasio AM, Persani L, Garagnani P, Franceschi C, Vitale G. Dicitore A, et al. Among authors: grassi es. Neuroendocrinology. 2022;112(6):580-594. doi: 10.1159/000518801. Epub 2021 Aug 2. Neuroendocrinology. 2022. PMID: 34348348 Free article.

10

8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.

Lucchi S, Calebiro D, de Filippis T, Grassi ES, Borghi MO, Persani L. Lucchi S, et al. Among authors: grassi es. PLoS One. 2011;6(6):e20785. doi: 10.1371/journal.pone.0020785. Epub 2011 Jun 10. PLoS One. 2011. PMID: 21695205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page